Impact of HLA diversity on donor selection in organ and stem cell transplantation

Human Heredity

Volumn 76, Issue 3-4, 2014, Pages 178-186

  Tiercy, Jean Marie ^a   Claas, Frans ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloreactivity; Epitopes; Haplotype frequency; Hematopoietic stem cell transplantation; HLA polymorphism; Kidney transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN;

ALGORITHM; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; CONFERENCE PAPER; DONOR SELECTION; GENETIC POLYMORPHISM; HAPLOTYPE; HEMATOPOIETIC STEM CELL; HISTOINCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; REGISTER; STEM CELL TRANSPLANTATION; ANTIBODY PRODUCTION; GENETIC VARIABILITY; GENETICS; ORGAN TRANSPLANTATION; ALLOIMMUNITY; B LYMPHOCYTE; GENOTYPE; GRAFT FAILURE; IMMUNE SYSTEM; T LYMPHOCYTE;

ANTIBODY FORMATION; DONOR SELECTION; GENETIC VARIATION; HLA ANTIGENS; HUMANS; ORGAN TRANSPLANTATION; STEM CELL TRANSPLANTATION;

EID: 84901493682     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000358798     Document Type: Conference Paper

References (45)

1. Shiina T, Hosomichi K, Inoko H, Kulski JK.The HLA genomic loci map. expression, interaction,diversity and disease. J Hum Genet2009; 54. 15-39.
2. Marsh SG, Albert ED, Bodmer WF, BontropRE, Dupont B, Erlich HA, Fernandez-Vina M,Geraghty DE, Holdsworth R, Hurley CK, LauM, Lee KW, Mach B, Maiers M, Mayr W,Müller CR, Parham P, Petersdorf EW, SasazukiT, Strominger JL, Svejgaard A, TerasakiPI, Tiercy J-M, Trowsdale J. Nomenclaturefor factors of the HLA system, 2010. TissueAntigens 2010; 75. 291-455.
3. Maiers M, Gragert L, Klitz W. High-resolutionHLA alleles and haplotypes in the UnitedStates population. Hum Immunol 2007; 68.779-788.
4. Eberhard HP, Feldmann U, Bochtler W, BaierD, Rutt C, Schmidt AH, Müller CR. Estimatingunbiased haplotype frequencies fromstem cell donor samples typed at heterogeneousresolutions. a practical study based onover 1 million German donors. Tissue Antigens2010; 76. 352-361.
5. Sanchez-Mazas A, Fernandez-Vina M, MiddletonD, Hollenbach JA, Buhler S, Di D, RajalingamR, Dugoujon JM, Mack SJ, ThorsbyE. Immunogenetics as a tool in anthropologicalstudies. Immunology 2011; 133. 143-164.
6. Fernandez-Vina M, Hollenbach JA, Lyke KE,Sztein MB, Klitz W, Cano P, Mack S, Single R,Brautbar C, Israel S, Raimondi E, Khoriaty E,Inati A, Amdreani M, Testi M, Moraes ME,Thomson G, Statsny P, Cao K. Tracking humanmigrations by the analysis of the distributionof HLA alleles, lineages and haplotypesin closed and open populations. PhilosTrans R Soc Lond B Biol 2012; 367. 820-829.
7. Schmidt AH, Solloch UV, Baier D, Stahr A,Wassmuth R, Ehninger G, Rutt C. Regionaldifferences in HLA antigen and haplotype frequencydistribution in Germany and their relevanceto the optimization of hematopoieticstem cell donor recruitment. Tissue Antigens2010; 76. 362-379.
8. Buhler S, Nunes JM, Nicoloso G, Tiercy JM,Sanchez-Mazas A. The heterogeneous geneticmakeup of the Swiss population. PLoS One2012; 7.e41400.
9. Mack SJ, Cano P, Hollenbach JA, et al. Commonand well-documented HLA alleles. 2012update to the CWD catalogue. Tissue Antigens2013; 81. 194-203.
10. Nunes E, Heslop H, Fernandez-Vina M, TavesC, Wagenknecht DR, Eisenbrey AB, FischerG, Poulton K, Wacker K, Hurley CK, NoreenH, Sacchi N. Definitions of histocompatibilitytyping terms. Blood 2011; 118.e180-e183.
11. Everly MJ, Rebellato LM, Haische CE, OzawaM, Parker K, Briley KP, Catrou PG, Bolin P,Kendrick WT, Kendrick SA, Harland RC,Terasaki PI. Incidence and impact of de novodonor-specific alloantibody in primary renalallografts. Transplantation 2013; 95. 410-417.
12. Duquesnoy RJ, Takemoto S, de Lange P, DoxiadisII, Schreuder GM, Persijn GG, Claas FH.HLAMatchmaker. a molecularly based algorithmfor histocompatibility determination.III. Effect of matching at the HLA-A,B aminoacid triplet level on kidney transplant survival.Transplantation 2003; 75. 884-889.
13. Tait BD, Susal C, Gebel HM, Nickerson PW,Zachary AA, Claas FHJ, Reed EF, Bray RA,Campbell P, Chapman JR, Coates PT, ColvinRB, Cozzi E, Doxiadis II, Fuggle SV, Gill J,Glotz D, Lachman N, Mohanakumar T,Suciu-Foca N, Sumitran-Holgersson S, TanabeK, Taylor CJ, Tyan DB, Webster A, ZeeviA, Opelz G. Consensus guidelines on testingand clinical management issues associatedwith HLA and non-HLA antibodies in transplantation.Transplantation 2013; 95. 19-47.
14. Dausset J. Leuco-agglutinins IV. Leuco-agglutininsand blood transfusion. Vox Sang1954; 4. 190-194.
15. Van Rood JJ, Eernisse JG, Van Leeuwen A.Leucocyte antibodies in sera from pregnantwomen. Nature 1958; 181. 1735-1736.
16. Payne R, Rolfs MR. Fetomaternal leucocyteincompatibility. J Clin Invest 1958; 37. 1756-1763.
17. Duquesnoy FJ, Marrari M. Correlation betweenTerasaki's HLA class I epitopes andHLAMatchmaker-defined eplets on HLA-A,-B and-C antigens. Tissue Antigens 2009; 74.117-133.
18. Duquesnoy RJ, Witvliet M, Doxiadis I, deFijter H, Claas FHJ. HLAMatchmaker-basedstrategy to identify acceptable HLA class Imismatches for highly sensitized transplantcandidates. Transpl Int 2004; 17. 22-30.
19. Macdonald WA, Chen Z, Gras S, ArchboldJK, Tynan FE, Clements CS, Bharadwaj M,Kjer-Nielsen L, Saunders PM, Wilce MC,Crawford F, Stadinsky B, Jackson D, BrooksAG, Purcell AW, Kappler JW, Burrows SR,Rossjohn J, McCluskey J. T cell allorecognitionvia molecular mimicry. Immunity 2009;31. 897-908.
20. Gökmen MR, Lombardi G, Lechler RI. Theimportance of the indirect pathway of allorecognitionin clinical transplantation. CurrOpin Immunol 2008; 20. 568-574.
21. Amir A, D'Orsogna L, Roelen DL, van LoenenMM, Hagedoorn RS, de Boer R, van derHoom MA, Kester MG, Doxiadis II, FlakenburgJH, Claas FH. Allo-HLA reactivity of virus-specific memory T cells is common.Blood 2010; 115. 146-157.
22. D'Orsogna LJ, Nguyen THO, Claas FHJ, WittC, Mifsud NA. Endogenous-peptide-dependentalloreactivity. new scientific insights andclinical implications. Tissue Antigens 2013;81. 399-407.
23. Persijn GG, Gabb BW, van Leeuwen A, NagtegaalA, Hoogeboom J, Van Rood JJ. Matchingfor HLA antigens of A,B and DR loci inrenal transplantation by Eurotransplant. Lancet1978; 1. 1278-1281.
24. Süsal C, Opelz G. Current role of human leukocyteantigen matching in kidney transplantation.Curr Opin Organ Transplant 2013; 18.438-444.
25. Kissmeyer-Nielsen F, Olsen S, Petersen VP,Fjeldborg O. Hyperacute rejection of kidneyallografts associated with preexisting humoralantibodies against donor cells. Lancet 1966;7465. 662-665.
26. Patel R, Terasaki PI. Significance of a positivecrossmatch in kidney transplantation. NewEngl J Med 1969; 280. 735-739.
27. Lachmann N, Terasaki PI, Budde K, LiefeldtL, Kahl A, Reinke P, Pratschke J, Rudolph B,Schmidt D, Salama A, Schönemann C. Antihumanleukocyte antigen and donor-specificantibodies by luminex posttransplant serve asbiomarkers of chronic rejection of renal allografts.Transplantation 2009; 87. 1505-1513.
28. Dankers M, Witvliet M, Roelen D, de LangeP, Korfage N, Persijn G, Duquesnoy R, DoxiadisII, Claas FH. The number of amino aciddifferences between patient and donor is predictivefor antibody reactivity against mismatchedHLA antigens. Transplantation2004; 77. 1236-1239.
29. Gralla J, Tong S, Wiseman AC. The impact ofhuman leucocyte antigen mismatching onsensitization rates and subsequent retransplantationafter first graft failure in paediatricrenal transplants recipients. Transplantation2013; 95. 1218-1224.
30. Duquesnoy RJ. HLAMatchmaker. a molecularlybased algorithm for histocompatibilitydetermination. I. Description of the algorithm.Hum Immunol 2002; 63. 339-352.
31. Claas FHJ, Rahmel A, Doxiadis II. Enhancedkidney allocation to highly sensitized patientsby the acceptable mismatch program. Transplantation2009; 88. 447-452.
32. Copelan EA. Hematopoietic stem-cell transplantation.New Engl J Med 2006; 354. 1813-1826.
33. Petersdorf EW. Optimal HLA matching inhematopoietic cell transplantation. CurrOpin Immunol 2008; 20. 588-593.
34. Shaw B, Arguello R, Garcia-Sepulveda CA,Madrigal JA. The impact of HLA genotypingon survival following unrelated donor haematopoieticstem cell transplantation. Br JHematol 2010; 150. 251-258.
35. Heemskerk MB, van Walraven SM, CornelissenJJ, Barge RM, Bredius RG, Egeler RM, LieJL, Révész T, Sintnicolaas K, Wulffraat NM,Donker AE, Hoogerbrugge PM, van Rood JJ,Claas FH, Oudshoorn M. How to improve thesearch for an unrelated haematopoietic stemcell donor. Faster is better than more! BoneMarrow Transplant 2005; 35. 645-652.
36. Tiercy JM, Nicoloso G, Passweg J, Schanz U,Seger R, Chalandon Y, Heim D, Güngör T,Schneider P, Schwabe R, Gratwohl A. Theprobability to identify a 10/10 HLA allelematchedunrelated donor is highly predictable.Bone Marrow Transplant 2007; 40. 515-522.
37. Tiercy JM. Unrelated hematopoietic stem celldonor matching probability and search algorithm.Bone Marrow Res 2012; 2012. 695018.
38. Jöris MM, Lankester AC, von dem Borne PA,Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, HaasnootGW, van der Zanden HG, van Walraven SM,van Rood JJ, Claas FH, Oudshoorn M. Theimpact of frequent HLA haplotypes in highlinkage disequilibrium on donor search andclinical outcome after unrelated hematopoieticSCT. Bone Marrow Transplant 2012. 48.483-490.
39. Petersdorf EW. The major histocompatibilitycomplex. a model for understanding graftversus-host disease. Blood 2013; 122. 1863-1872.
40. Hirv K, Bloch K, Fischer M, Einsiedler B,Schrezenmeier H, Mytilineos J. Prediction ofduration and success rate of unrelated hematopoieticstem cell donor searches based onthe patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. Bone MarrowTransplant 2009; 44. 433-440.
41. Pédron B, Guérin-El Khourouj V, Dalle JH,Ouachée- Chardin M, Yakouben K, CorroyezF, Auvrignon A, Petit A, Landman-Parker J,Leverger G, Baruchel A, Sterkers G. Contributionof HLA-A/B/C/DRB1/DQB1 commonhaplotypes to donor search outcome in unrelatedhematopoietic stem cell transplantation.Biol Blood Marrow Transplant 2011; 17.1612-1618.
42. Querol S, Mufti GJ, Marsh SGE, Pagliuca A,Little AM, Shaw BE, Jeffery R, Garcia J, GoldmanJM, Madrigal JA. Cord blood stem cellsfor hematopoietic stem cell transplantation inthe UK. how big should the bank be Hematologica2009; 94. 536-541.
43. Rosenmayr A, Pointner-Prager M, WinklerM, Mitterschiffhaler A, Pelzmann B, Bozic L,Pichler SK, Tüchler H, Fae I, Fischer G. TheAustrian bone marrow donor registry. providingpatients in Austria with unrelated donorsfor transplant-a worldwide cooperation.Transfus Med Hemother 2012; 38. 292-299.
44. Pidala J, Kim J, Schell M, Lee SJ, Hillgruber R,Nye V, Ayala E, Alsina M, Betts B, Bookout R,Fernandez HF, Field T, Locke FL, NishihoriT, Ochoa JL, Perez L, Pekins J, Shapiro J, TateC, Tomblyn M, Anasetti C. Race/ethnicity affectsthe probability of finding an HLA-A,-B,-C and-DRB1 allele-matched unrelated donorand likelihood of subsequent transplantutilization. Bone Marrow Transplant 2013; 48.346-350.
45. Tambur A, Claas FHJ. Towards HLA epitopematching in clinical transplantation. Am JTransplant 2013; 13. 59-60.